Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Aug 28;21(1):319.
doi: 10.1186/s12905-021-01455-6.

Fertility preservation in patients with uterus didelphys and endometrial carcinoma: a case report

Jiao Yu  1 , Jing Shang  1 , Hongwu Wen  1 , Yang Xu  2
Affiliations
Case Reports

Fertility preservation in patients with uterus didelphys and endometrial carcinoma: a case report

Jiao Yu et al. BMC Womens Health. .

Abstract

Background: Endometrial cancer combining uterus didelphys is quite rare clinically which partially explains that there is no discussion about young patients' fertility preservation and follow up of tumor outcome.

Case presentation: In this article, we report a case of unilateral endometrial carcinoma found in a young patient with uterus didelphys who was treated with high-efficiency progesterone due to unfinished child-bearing. During the follow-up, the affected uterine endometrium was not reversed by progesterone. So, the patient underwent the abdominal surgery with the left uterus and left fallopian tube resection. We performed three consecutive immunohistochemical studies of the contralateral uterine endometrium to verify the safety of preserving the contralateral uterus and its appendages which preserved her fertility.

Conclusions: Endometrial cancer occurring in patients with uterus didelphys is quite rare in child-bearing age. In this case report, we preserved the patient's contralateral uterus based on patient's strong needs and negative IHC analysis of the preserved side uterine endometrium. However, the tumor and fertility outcome require more follow-up.

Keywords: Endometrial cancer; Fertility preservation; IHC analysis; Uterus didelphys.

PubMed Disclaimer

Conflict of interest statement

No authors have any potential conflict of interests.

Similar articles

See all similar articles

Cited by

References

    1. Roly ZY, Backhouse B, Cutting A, et al. The cell biology and molecular genetics of Mullerian duct development. Wiley Interdiscip Rev Dev Biol. 2018;7(3):e310. - PubMed
    1. Chandler TM, Machan LS, Cooperberg PL, et al. Mullerian duct anomalies: from diagnosis to intervention. Br J Radiol. 2009;82(984):1034–1042. doi: 10.1259/bjr/99354802. - DOI - PMC - PubMed
    1. Heinonen PK. Clinical implications of the didelphic uterus: long-term follow-up of 49 cases. Eur J Obstet Gynecol Reprod Biol. 2000;91(2):183–190. doi: 10.1016/S0301-2115(99)00259-6. - DOI - PubMed
    1. Emons G, Steiner E, Vordermark D, et al. Part 2 with recommendations on the therapy and follow-up of endometrial cancer, palliative care, psycho-oncological/psychosocial care/rehabilitation/patient information and healthcare facilities. Geburtshilfe Frauenheilkd. 2018;78(11):1089–1109. doi: 10.1055/a-0715-2964. - DOI - PMC - PubMed
    1. Orvis GD, Behringer RR. Cellular mechanisms of Mullerian duct formation in the mouse. Dev Biol. 2007;306(2):493–504. doi: 10.1016/j.ydbio.2007.03.027. - DOI - PMC - PubMed

Publication types

LinkOut - more resources